S hares of global vaccine makers were muted on Tuesday as investors and analysts took a "wait and watch" approach after U.S.

The main reason for the downturn in Moderna’s stock is a significant drop in the demand for its COVID-19 vaccine.

(Reuters) -Shares of global vaccine makers were muted on Tuesday as investors and analysts took a "wait and watch" approach ...

While the news isn’t great for vaccine manufacturers, it could have been worse. Shares of pure vaccine play Moderna rose 0.3% ...

The U.S. Secretary of Health has removed the entire CDC vaccine advisory committee. He has two weeks to appoint a new panel ...

Moderna – at the moment embroiled in a patent dispute with Pfizer and BioNTech over mRNA intellectual property – is also testing a vaccine that combines COVID-19 and flu in a single jab in a ...

A new COVID variant - NB 1.8.1 - is creeping across California; here are the symptoms to watch for, and vaccinations you'll ...

All of which brings us to May 2020, when the federal government tasked the pharmaceutical industry with producing COVID ...

Moderna vaulted to the forefront of biotech, becoming a major pillar of the region’s economy. But Robert F. Kennedy Jr.’s ...

US health secretary Robert F Kennedy Jr has fired all 17 members of a panel of vaccine experts and is in the process of ...

A new COVID variant - NB 1.8.1 - is creeping across the country; here are the symptoms to watch for, and vaccinations you'll ...

ACIP members are required to disclose everything as part of the application process, said one fired member who spoke on ...